All News about Lexaria Bioscience Corp
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent
July 25, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2022/06/22/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/21/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.